内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

皮肤再生医疗技术在糖尿病性创面分期分级诊疗中的规范化应用方案专家共识

2021-09-22 中国中西医结合学会烧伤专业委员会 中国烧伤创疡杂志

皮肤再生

皮肤再生医疗技术(MEBT/MEBO)治疗糖尿病性创面已在临床应用多年,且取得了较好疗效。

中文标题：

皮肤再生医疗技术在糖尿病性创面分期分级诊疗中的规范化应用方案专家共识

发布机构：

中国中西医结合学会烧伤专业委员会

发布日期：

2021-09-22

简要介绍：

皮肤再生医疗技术(MEBT/MEBO)治疗糖尿病性创面已在临床应用多年,且取得了较好疗效。针对糖尿病性创面尤其是糖尿病足创面临床表现多样、发病机制复杂、难以治愈等特点,临床应用MEBT/MEBO时需进行更有针对性,更具系统化、规范化、个体化的操作指导,形成共识以便能够准确指导临床治疗。在此背景下,本项目组在前期文献研究基础上结合多年临床经验制订了《皮肤再生医疗技术在糖尿病性创面分期分级诊疗中的规范化应用方案》,该方案将MEBT/MEBO与现代慢性难愈合创面的"创面床准备"理论相结合,对糖尿病性创面MEBT/MEBO的应用进行分期分级论述,详细讲解了 MEBT/MEBO规范化、细致化、具体化的操作流程及注意事项,但相关基础治疗及其他局部治疗方法不在本方案探讨范围。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=皮肤再生医疗技术在糖尿病性创面分_省略_级诊疗中的规范化应用方案专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d8f581c002235600, title=皮肤再生医疗技术在糖尿病性创面分期分级诊疗中的规范化应用方案专家共识, enTitle=, guiderFrom=中国烧伤创疡杂志, authorId=0, author=, summary=皮肤再生医疗技术(MEBT/MEBO)治疗糖尿病性创面已在临床应用多年,且取得了较好疗效。, cover=https://img.medsci.cn/20211025/1635140959382_1608702.jpg, journalId=0, articlesId=null, associationId=2040, associationName=中国中西医结合学会烧伤专业委员会, associationIntro=中国中西医结合学会烧伤专业委员会, copyright=0, guiderPublishedTime=Wed Sep 22 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">皮肤再生医疗技术(MEBT/MEBO)治疗糖尿病性创面已在临床应用多年,且取得了较好疗效。针对糖尿病性创面尤其是糖尿病足创面临床表现多样、发病机制复杂、难以治愈等特点,临床应用MEBT/MEBO时需进行更有针对性,更具系统化、规范化、个体化的操作指导,形成共识以便能够准确指导临床治疗。在此背景下,本项目组在前期文献研究基础上结合多年临床经验制订了《皮肤再生医疗技术在糖尿病性创面分期分级诊疗中的规范化应用方案》,该方案将MEBT/MEBO与现代慢性难愈合创面的"创面床准备"理论相结合,对糖尿病性创面MEBT/MEBO的应用进行分期分级论述,详细讲解了 MEBT/MEBO规范化、细致化、具体化的操作流程及注意事项,但相关基础治疗及其他局部治疗方法不在本方案探讨范围。&nbsp;</span></p>, tagList=[TagDto(tagId=114408, tagName=皮肤再生)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=114408, guiderKeyword=皮肤再生, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=21520, appHits=51, showAppHits=0, pcHits=253, showPcHits=21468, likes=1, shares=6, comments=3, approvalStatus=1, publishedTime=Mon Oct 25 15:58:37 CST 2021, publishedTimeString=2021-09-22, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Mon Oct 25 14:19:05 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 10:33:13 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=皮肤再生医疗技术在糖尿病性创面分_省略_级诊疗中的规范化应用方案专家共识.pdf)])
皮肤再生医疗技术在糖尿病性创面分_省略_级诊疗中的规范化应用方案专家共识.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1080617, encodeId=81c5108061e30, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:46:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072684, encodeId=591710e2684b9, content=`、∴……学了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Mon Nov 22 06:59:58 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069135, encodeId=74e11069135ad, content=酷, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8625648556, createdName=ms6000001197628119, createdTime=Wed Nov 10 23:44:36 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
    2021-12-16 龙珠

    学习好资料

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1080617, encodeId=81c5108061e30, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:46:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072684, encodeId=591710e2684b9, content=`、∴……学了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Mon Nov 22 06:59:58 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069135, encodeId=74e11069135ad, content=酷, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8625648556, createdName=ms6000001197628119, createdTime=Wed Nov 10 23:44:36 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
    2021-11-22 ms9000000080461052

    `、∴……学了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1080617, encodeId=81c5108061e30, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:46:12 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072684, encodeId=591710e2684b9, content=`、∴……学了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbbc5723650, createdName=ms9000000080461052, createdTime=Mon Nov 22 06:59:58 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069135, encodeId=74e11069135ad, content=酷, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8625648556, createdName=ms6000001197628119, createdTime=Wed Nov 10 23:44:36 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
    2021-11-10 ms6000001197628119

    酷

    0